PLUS THERAPEUTICS, INC. Files Form 8-K with SEC Detailing Shareholder Director Nomination Procedures and Company Information
Plus Therapeutics Announces Date and Details for 2026 Annual...
Sign in to continue:
Plus Therapeutics Announces Date and Details for 2026 Annual...
Turtle Beach Corporation Q4 and Full Year 2025 Financial Res...
TREASURE GLOBAL INC (TGL) - 8-K Filing: Key Details for Inve...
AMREP Corporation Reports Strong Q3 Fiscal 2026 Results ...
California BanCorp Declares Cash Dividend: Investor Report ...
Axcelis Announces CFO Transition and Interim Appointment ...
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion...
Broker Name: Lim & Tan Securities Date of Report: 13 March 2...
Broker Name: Maybank Investment Bank Berhad Date of Report: ...
NCR Atleos Corporation Announces Successful Consent Solicita...